Topic collection

Melanocortin peptides

Approval of one product does not prove another molecule, route, population, or cosmetic claim is supported.

3 peptide records2 with Established evidence11 fact checks

Start here

Start with these posts

Learn why two approved medicines with different uses do not prove broad tanning or performance claims.

Peptide records

Open each record to see its evidence.

Compare evidence ↗
More about this topic

These three peptides act on melanocortin receptors, proteins that receive body signals. Bremelanotide (PT-141) has an FDA-approved product for one specific use. Afamelanotide (Scenesse) has an FDA-approved implant for a rare disease. Melanotan II is rated Insufficient, and its review found no approved product in any country checked.

Approval for two specific conditions does not support broad tanning, sexual-desire, or performance claims for a third peptide. It also does not support another way of using it or an unapproved product. Each review names the exact condition and result studied.

Questions to ask about this topic

  1. 01

    Which melanocortin receptor and product are involved?

  2. 02

    What exact condition and result did the study measure?

  3. 03

    Is a specific approved use being turned into a claim of benefits for everyone?

  4. 04

    What remains unknown about safety, quality, or personal use?